Last reviewed · How we verify

Administering propofol

Iuliu Hatieganu University of Medicine and Pharmacy · FDA-approved active Small molecule

Propofol is a rapid-acting intravenous sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system.

Propofol is a rapid-acting intravenous sedative-hypnotic agent that enhances inhibitory GABAergic neurotransmission in the central nervous system. Used for Induction of general anesthesia, Maintenance of general anesthesia, Sedation for diagnostic and therapeutic procedures.

At a glance

Generic nameAdministering propofol
SponsorIuliu Hatieganu University of Medicine and Pharmacy
Drug classIntravenous sedative-hypnotic
TargetGABA-A receptor
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Propofol potentiates the effect of the inhibitory neurotransmitter GABA by binding to GABA-A receptors, leading to hyperpolarization of neuronal membranes and depression of central nervous system activity. This results in rapid onset of unconsciousness and sedation, making it suitable for induction and maintenance of general anesthesia as well as procedural sedation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results